Results 71 to 80 of about 1,612,376 (366)

The Burden of Rabies in Tanzania and Its Impact on Local\ud Communities [PDF]

, 2013
Rabies remains a major public health threat in many parts of the world and is responsible for an estimated 55,000 human deaths annually. The burden of rabies is estimated to be around US$20 million in Africa, with the highest financial expenditure being ...
Cleaveland, Sarah, Ferguson, Heather, Hampson, Katie, Lembo, Tiziana, Sambo, Maganga, Simon, Cleophas, Urassa, Honorati   +6 more
core   +9 more sources

Analyzing Subnational Immunization Coverage to Catch up and Reach the Unreached in Seven High-Priority Countries in the Eastern Mediterranean Region, 2019–2021

Vaccines
Yearly national immunization coverage reporting does not measure performance at the subnational level throughout the year and conceals inequalities within countries.
Kamal Fahmy, Quamrul Hasan, Md Sharifuzzaman, Yvan Hutin   +3 more
doaj   +1 more source

PRODUCTION OF HYBRID RECOMBINANT PROTEIN Flu-Chim, CONTAINING INFLUENZA VIRUSES A AND B MAJOR EPITOPES

Инфекция и иммунитет, 2017
The influenza virus is highly contagious diseases of people, birds and mammals. Approximately 250 000– 500 000 deaths are caused by influenza epidemics worldwide yearly, and the death number may be up to millions in a possible influenza pandemic ...
I. V. Dukhovlinov, O. A. Dobrovolskaia, A. I. Orlov   +2 more
doaj   +1 more source

A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade

Viruses, 2020
On average, there are 3–5 million severe cases of influenza virus infections globally each year. Seasonal influenza vaccines provide limited protection against divergent influenza strains.
Brigette N. Corder, Brianna L. Bullard, Gregory A. Poland, Eric A. Weaver   +3 more
doaj   +1 more source

Virus-Vectored Influenza Virus Vaccines

Viruses, 2014
Despite the availability of an inactivated vaccine that has been licensed for >50 years, the influenza virus continues to cause morbidity and mortality worldwide.
Ralph A. Tripp, S. Mark Tompkins
doaj   +1 more source

Invasive meningococcal disease in the Veneto region of Italy: A capture-recapture analysis for assessing the effectiveness of an integrated surveillance system [PDF]

, 2017
open8noBACKGROUND: Epidemiology of Neisseria meningitidis has been changing since the introduction of universal vaccination programmes against meningococcal serogroup C (MenC) and meningococcal serogroup B (MenB) has now become dominant.
Baldo, Vincenzo, Baldovin, Tatjana, Bertoncello, Chiara, Cocchio, Silvia, Furlan, Patrizia, Lazzari, Roberta, Russo, Francesca, Saia, Mario   +7 more
core   +1 more source

Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines

Human Vaccines & Immunotherapeutics, 2021
The universal administration of pneumococcal conjugate vaccines (PCVs) had been demonstrated as an effective way to prevent Streptococcus pneumoniae infection.
Qian-qian Du, W. Shi, Dan Yu, K. Yao
semanticscholar   +1 more source

Trends of influenza B during the 2010–2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy [PDF]

, 2018
Influenza A and B viruses are responsible for respiratory infections, representing globally seasonal threats to human health. The 2 viral types often co-circulate and influenza B plays an important role in the spread of infection.
Alicino C., Ansaldi F., Calamusa G., Canepa P., Colomba G. M. E., Orsi A., Pojero F., Tramuto F., Trucchi C., Vitale F.   +9 more
core   +1 more source

Progress in the Development of Universal Influenza Vaccines

Viruses, 2020
Influenza viruses pose a significant threat to human health. They are responsible for a large number of deaths annually and have a serious impact on the global economy. There are numerous influenza virus subtypes, antigenic variations occur continuously,
Wenqiang Sun, Tingrong Luo, Wenjun Liu, Jing Li   +3 more
doaj   +1 more source

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines

Frontiers in Immunology, 2022
Given pandemic risks of zoonotic SARS-CoV-2 variants and other SARS-like coronaviruses in the future, it is valuable to perform studies on conserved antigenic sites to design universal SARS-like coronavirus vaccines.
Siling Wang, Dinghui Wu, Hualong Xiong, Juan Wang, Zimin Tang, Zihao Chen, Yizhen Wang, Yali Zhang, Dong Ying, Xue Lin, Chang Liu, Shaoqi Guo, Weikun Tian, Yajie Lin, Xiaoping Zhang, Quan Yuan, Hai Yu, Tianying Zhang, Zizheng Zheng, Ningshao Xia   +19 more
doaj   +1 more source